Skip to content

Clinical trials

Phase 3 Body Weight Changes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Body Weight Changes Phase: Phase 3 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20071
20101
20121
20171
20221
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Not yet recruiting2
Terminated2
Withdrawn2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology2
Viking Therapeutics, Inc.2
Eli Lilly and Company1
Instituto de Investigación Hospital Universitario La Paz1
Mount Sinai Hospital, Canada1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Prism Health North Texas1
Solvay Pharmaceuticals1
University of Illinois at Chicago1
University of South Florida1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Body Weight Changes13
Obesity5
Weight Loss4
Body Weight2
Cachexia2
Overweight2
Schizophrenia2
Acquired Immunodeficiency Syndrome1
Anorexia1
Astrocytoma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.